housing Grant Search

The following government grants in the FederalGrants.com database contain the term housing in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

 

 

 

 
 
 Grant TitleCFDAFunding Number
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) 93.853 PAR-22-028
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) 93.865 PAR-21-354
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) 93.865 PAR-21-355
Enhancing US Clinical Laboratory Workforce Capacity 93.322 CDC-RFA-OE22-2202
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) 93.853 PAR-22-030
Promoting Equitable Access to Language Services in Health and Human Services 93.137 MP-CPI-22-005
FY22 BLM Bureau-Wide National Landscape Conservation System 15.248 L22AS00071
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) 93.398 RFA-CA-21-060
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) 93.398 RFA-CA-21-061
Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs, and TB in the U.S. Affiliated Pacific Islands 93.116 CDC-RFA-PS23-2302
Community-Driven Approaches to Address Factors Contributing to Structural Racism in Public Health 93.137 MP-CPI-22-003
Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) 93.866 RFA-AG-22-026
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) 93.398 RFA-CA-21-062
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) 93.394 RFA-CA-22-004
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) 93.394 RFA-CA-22-003
Reduce Health Disparities and Improve Traumatic Brain Injury (TBI) Related Outcomes Through the Implementation of CDC's Pediatric Mild TBI Guideline 93.136 RFA-CE-22-007
RePORT International Coordinating Center (RICC) (U01 Clinical Trial Not Allowed) 93.855 RFA-AI-21-078
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) 93.393, 93.396 PAR-22-061
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) 93.393, 93.396 PAR-22-062
Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed) 93.853, 93.866 PAR-22-059
FY 2022 AmeriCorps Seniors - American Rescue Plan Senior Demonstration Program 94.017 AC-11-01-21
FY21 NOFO Housing Counseling Training Grant Program 14.316 FR-6500-N-30
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) 93.310 PAR-22-054
Home and Community-Based Physical Activity Interventions to Improve the Health of Wheelchair Users (R01 Clinical Trial Required) 93.865 RFA-HD-22-017
Eastern Nevada Conservation, Recreation and Development 15.017 L22AS00070
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) 93.213, 93.233, 93.279, 93.307, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.867 RFA-AT-22-004
Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) 93.853 PAR-22-053
NIJ Multisite Impact and Cost-Efficiency Evaluation of Veterans Treatment Courts, Fiscal Year 2022 16.560 O-NIJ-2022-171012
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) 93.213, 93.233, 93.279, 93.307, 93.313, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.867 RFA-AT-22-005
Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed) 93.310 RFA-RM-22-004
Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) 93.866 RFA-AG-23-002
Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) 93.310 RFA-RM-22-005
Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional 93.103 RFA-FD-22-016
Cellular Senescence Network: Murine Tissue Mapping Centers (U54 - Clinical Trial Not Allowed) 93.310 RFA-RM-22-003
Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) 93.865 RFA-HD-22-023
Using Data Linkage to Understand Suicide Attempts, Self-Harm and Unintentional Drowning Deaths (U01) 93.136 RFA-CE-22-008
Rigorous Evaluation of Strategies to Prevent Overdose through Linking People with Illicit Substance Use Disorders to Recovery Support Services 93.136 RFA-CE-22-010
Research Grants to Evaluate the Effectiveness of Physical Therapy-based Exercises and Movements Used to Reduce Older Adults Falls (U01) 93.136 RFA-CE-22-006
In Vitro Approaches to Evaluate and Compare the Adhesion Performance of Transdermal and Topical Delivery Systems (TDS) (U01) Clinical Trial Required 93.103 RFA-FD-22-015
Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional) 93.866 RFA-AG-23-001
Search Results 2801-2840 of 17730
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 [Next]

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com